RemedyRepack Recalls Humulin 70/30 Vials Due to Incorrect Storage Instructions
RemedyRepack, Inc. is recalling 65 vials of Humulin 70/30 insulin due to incorrect storage instructions on the label.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (incorrect storage instructions) with no reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
RemedyRepack, Inc. is recalling 65 vials of Humulin 70/30, 100 Units/mL Injection. The product was originally manufactured by Lilly USA, LLC and repackaged by RemedyRepack, Inc. The recall is being conducted because the product labels contain incorrect storage instructions.
The affected products are identified by the following lot numbers and expiration dates: B0080702-042715 and B0080695-042715 (Exp 07/2017), and B0097444-082015 and B0097443-082015 (Exp 02/2018). The NDC for the product is 52125-0415-08. The recall is classified as Class II by the FDA.
Consumers who have these specific vials should stop using them and contact their healthcare provider or the recalling firm for further instructions. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- Humulin 70/30, 100 Units/mL Inj, Qty: 10 mL Vial, MFG by: Lilly USA, LLC, Indianapolis, IN 46285, Repackaged by: Remedy Repack, Inc, 625 Kolter Dr, Indiana, PA 15701, NDC 52125-0415-08
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug — Insulin
- Hazard
- Affected units
- 65
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- LOT # B0080702-042715
- B0080695-042715
- B0097444-082015
- Exp 07/2017
- B0097443-082015
- Exp 02/2018.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by RemedyRepack Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · RemedyRepack Inc.
See all →- ModerateClindamycin HCl Capsule 300 mg repackaged by RemedyRePack Inc.
FDA (Drugs) · 2025-05-14
- ModerateClindamycin HCl 300 mg Capsule Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-30
- HighCarvedilol 25 mg tablets recalled due to N-nitroso impurity above limit
FDA (Drugs) · 2025-02-12
- HighDuloxetine delayed-release capsules recalled due to manufacturing impurity
FDA (Drugs) · 2025-01-01
- HighPotassium Chloride Extended Release Capsules Recalled for Dissolution Defect
FDA (Drugs) · 2024-07-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02